home / stock / irix / irix news


IRIX News and Press, IRIDEX Corporation From 08/12/25

Stock Information

Company Name: IRIDEX Corporation
Stock Symbol: IRIX
Market: NASDAQ
Website: iridex.com

Menu

Get IRIX Alerts

News, Short Squeeze, Breakout and More Instantly...

IRIX - IRIDEX GAAP EPS of -$0.06, revenue of $13.6M

2025-08-12 16:14:28 ET More on IRIDEX Financial information for IRIDEX Read the full article on Seeking Alpha For further details see: IRIDEX GAAP EPS of -$0.06, revenue of $13.6M

IRIX - Iridex Reports Second Quarter 2025 Financial Results

MOUNTAIN VIEW, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial r...

IRIX - Expected US Company Earnings on Tuesday, August 12th, 2025

Reeds Inc. (REED) is expected to report $-0.04 for Q2 2025 Jerash Holdings (US) Inc. (JRSH) is expected to report for Q1 2026 Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2025-06-30 Verde Clean Fuels Inc. (VGAS) is expected to report for Q2 2025 Mobile In...

IRIX - Expected earnings - IRIDEX Corporation

IRIDEX Corporation (IRIX) is expected to report for Q2 2025

IRIX - Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025

MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company pla...

IRIX - Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, announced today that the first patie...

IRIX - Iridex targets cash flow breakeven in 2025 as operational discipline and strategic investment reshape outlook

2025-05-13 21:06:09 ET More on IRIDEX IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Call Transcript IRIDEX Changes Course IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript) Iridex outlines 2025 growth strategy with $10M strategic inves...

IRIX - IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Call Transcript

2025-05-13 21:05:37 ET IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Conference Call May 13, 2025, 17:00 ET Company Participants Trip Taylor - IR Patrick Mercer - CEO, President & Director Romeo Dizon - CFO Conference Call Participants Presen...

IRIX - IRIDEX GAAP EPS of -$0.10, revenue of $11.9M

2025-05-13 16:22:30 ET More on IRIDEX IRIDEX Changes Course IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript) IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript Iridex outlines 2025 growth strategy with $10M strategic investment ...

IRIX - Iridex Reports First Quarter 2025 Financial Results

MOUNTAIN VIEW, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial re...

Previous 10 Next 10